Access cutting-edge recessive dystrophic epidermolysis bullosa treatment through this clinical trial at a research site in Galveston. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Galveston location
Preparing your pre-screening questions…
Access recessive dystrophic epidermolysis bullosa specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related recessive dystrophic epidermolysis bullosa treatment provided free
Check if you qualify for this recessive dystrophic epidermolysis bullosa clinical trial in Galveston, TX
No-Cost Study Care
Local to Galveston
Convenient for TX residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this observational study is to evaluate the long-term safety and wound healing durability (up to 15 years) for participants with Recessive Dystrophic Epidermolysis Bullosa (RDEB) who were treated with pz-cel. The main questions it aims to answer are: * The long-term safety profile of pz-cel. * The wound healing durability of pz-cel. * The occurrence of all malignancies after treatment with pz-cel, regardless of type or location, in individuals who received pz-cel treatment for RDEB in the post-marketing setting. Participants will then be followed annually up to 15 years post-treatment. Assessments will occur via remote data collection. If the participants provider determines an office visit is necessary after the first year, some of this data can be collected in person as well. Annual assessments will include, but are not limited to: * Review of Adverse Events (AEs), Serious Adverse Events (SAEs), hospitalizations, and any evidence of malignancies and potential retroviral infection * Wound-healing durability data collection via the modified Caregiver Global Impression of Change for Wound Healing * Any changes in concomitant medications and procedures.
Sponsor: Abeona Therapeutics, Inc
Yes, this clinical trial (NCT07700966) has an active research site in Galveston, TX that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for recessive dystrophic epidermolysis bullosa treatment options in Galveston, TX, this clinical trial (NCT07700966) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Galveston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced recessive dystrophic epidermolysis bullosa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all recessive dystrophic epidermolysis bullosa clinical trials near you to find additional studies recruiting in your area.
See all sleep apnea clinical trials recruiting in Galveston — not just this study.
Browse Sleep Apnea Trials in Galveston →